BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 28
• 29
• 30

• Career Advice

  Creating a Resume for a Position in Agricultural Biotechnology

  December 15, 2009

   · 

  2 min read
• Job Trends

  Ambrilia Biopharma Inc. Closes Manufacturing Facility, Cuts Jobs

  December 15, 2009

   · 

  4 min read
• Policy

  Spinal Restoration, Inc. Reaches Agreement with FDA on the Special Protocol Assessment (SPA) for the Phase 3 Trial of the Biostat(R) System

  December 15, 2009

   · 

  2 min read
• FDA

  OraSure Technologies, Inc. Receives CE Mark for OraQuick(R) Rapid HCV Antibody Test

  December 15, 2009

   · 

  7 min read
• Biotech Beach

  CalciMedica Achieves Milestone and Draws Down Second Tranche of $12 Million Series C Financing

  December 15, 2009

   · 

  1 min read
• Drug Development

  Data Safety Monitoring Board (DSMB) Approves Advancement to Intermediate Dose Level of Pluristem Therapeutics’s PLX-PAD

  December 15, 2009

   · 

  1 min read
• Business

  Isis Pharmaceuticals, Inc. And Alnylam Pharmaceuticals Announce Notice of Allowance for New U.S. Patent Application Broadly Covering RNAi Therapeutics

  December 15, 2009

   · 

  1 min read
• Business

  Global Med Technologies Welcomes Pennsylvania Hospital Group as New Client Jameson Health System Chooses SafeTrace Tx(R) Transfusion Solution

  December 15, 2009

   · 

  2 min read
• Genetown

  Genocea Biosciences Awarded Grant for the Development of Chlamydia Vaccines from the University of Pittsburgh Medical Center’s Sexually Transmitted Infections Cooperative Research Center

  December 15, 2009

   · 

  1 min read
• Business

  The Ludwig Institute For Cancer Research (LICR) and Pro-Pharmaceuticals, Inc. Collaborate to Test DAVANAT(R)'s Ability to Enhance the Function of Anti-Tumor T Lymphocytes

  December 15, 2009

   · 

  1 min read